ProfileGDS4459 / ENSG00000184992
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 33% 33% 42% 15% 36% 29% 45% 35% 38% 38% 26% 45% 30% 38% 39% 21% 28% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.8733
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.8633
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.0642
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.2715
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.8736
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.6329
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.2345
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.7635
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.8738
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.9638
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.4426
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.1445
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.5930
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.0438
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.939
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.4621
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.6428